Raiffeisen Bank International’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,260
Closed -$35.1K 872
2025
Q2
$34.8K Hold
1,260
﹤0.01% 506
2025
Q1
$35.7K Sell
1,260
-2,758
-69% -$97.9K ﹤0.01% 521
2024
Q4
$159K Buy
+4,018
New +$192K ﹤0.01% 469

Other funds holding MRNA

Raiffeisen Bank International's MRNA Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Moderna (MRNA) in Q3 2025, closing a stake of 1,260 shares — an estimated $35.1K sold.

Raiffeisen Bank International first reported a position in MRNA in Q4 2024 and held it in 3 quarters. The position peaked at $159K in Q4 2024. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 1,260 Moderna shares in Q3 2025, an estimated $35.1K.
  • Raiffeisen Bank International first reported a position in Moderna in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Moderna position peaked at $159K in Q4 2024.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.